VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 0960294
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: tongue itching; lips itching; face feels flushed; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; left hand is tingling or numb (the palm)/left hand that's puffy and tingling; palm of left hand was itchy; inside of nose; it feels like someone is pinching nose/It's swelling; inside of nose; it feels like someone is pinching nose/It's swelling; face has a rashly feeling; This is a spontaneous report from a contactable consumer reported for self. This 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on an unspecified date at single dose in left arm for COVID-19 immunisation. The patient medical history and concomitant mediations not provided. The patient reported that she had the vaccine at her work, waited 15 minutes and left the clinic. About 20 minutes then, her tongue was itching, lips were itching; face felt flushed. Face had a rashly feeling. Her left hand was tingling or numb (the palm). Her palm of left hand was tingling and itchy. The inside of nose; it feels like someone is pinching nose. It was swelling. The patient stated "Whenever I get stung by bees, this is how I feel". The patient stated that it was mild. She stated she was having a reaction, but not severe enough maybe it will subside. Her left arm is where she got the injection and it was left hand that was puffy and tingling. The patient stated that she also had N95 mask on and she guess she get that reaction from it. The patient stated that she was just wondering what she should do, if she should just go by some diphenhydramine hydrochloride (BENADRYL). The outcome of events was not reported. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960295
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Injection site pain; chills; fever; headache; muscle pain; nausea; This is a spontaneous report from a contactable healthcare professional (patient). A 66-year-old female patient received the second dose of BNT162B2 (Pfizer, lot number: EL3246), intramuscularly in left arm on 08Jan2021 09:30 at single dose for COVID-19 immunization. Medical history included known allergies: sulfa drugs. Concomitant medications were not reported. Patient previously received the first dose of BNT162B2 (lot number: EK5730), intramuscularly in left arm on 21Dec2020 17:00 for COVID-19 immunization. Patient experienced injection site pain, chills, fever, headache, muscle pain, and nausea 12 hours after second vaccine on 08Jan2021 22:00. No treatment was received. Patient was recovered from these events. No follow-up attempts are possible; no information is expected.

Other Meds:

Current Illness:

ID: 0960296
Sex: F
Age:
State: MA

Vax Date: 12/17/2020
Onset Date: 12/18/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Mild myalgias 36h after on 19Dec2020 02:30; Intermittent mild Dizziness and nausea 24h after vaccine; Intermittent mild Dizziness and nausea 24h after vaccine; Pain at side of puncture, unable to lift arm from 12h to 40 hours after; unable to lift arm from 12h to 40 hours after; This is a spontaneous report from a contactable Physician(patient). A 32-year-old female patient received first dose BNT162B2 (lot number EH9899) , via an unspecified route of administration at Arm Right on 17Dec2020 14:30 at the 32 years old at single dose for COVID-19 immunization. The medical history was not reported. The concomitant medication was levothyroxine. The patient experienced Pain at side of puncture on 18Dec2020 12:00, unable to lift arm from 12h on 18Dec2020 02:30 to 40 hours after on 20Dec2020 06:30, Intermittent mild Dizziness and nausea 24h after vaccine on 18Dec2020 14:30, Mild myalgias 36h after on 19Dec2020 02:30, resolved at 48h post vaccine on 19Dec2020 14:30. There was no treatment received for all the adverse events. There was no other vaccine in four weeks. The outcome of the events was Recovered.

Other Meds:

Current Illness:

ID: 0960297
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Local injection site redness swelling heat and pain/local site is very painful and still red; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain; Local injection site redness swelling heat and pain/local site is very painful; headache; extreme fatigue; diarrhea; This is a spontaneous report from a contactable Nurse (patient). A 39-year-old female patient received the second dose of BNT162b2 (Lot number: EL1284), intramuscular in left arm on 08Jan2021 15:00 at single dose for covid-19 immunization. Medical history included Hemeplegic migraines, wolff-parkinson-white syndrome (wpw), hypertension (htn), known allergies: Penicillin (PCN) and Sulfonamide (sulfa). The patient's concomitant medication was unspecified product. The patient previously received the first dose of BNT162b2 (Lot number: EH9899), at the age of 39-year-old, intramuscular in left arm on 18Dec2020 15:00 at single dose for covid-19 immunization. The patient experienced local injection site redness swelling heat and pain. Also noted was headache, extreme fatigue and diarrhea. But local site is very painful and still red day 3. The events were occurred at 12:00 on 09Jan2021. The patient did not receive the treatment for the events. The patient was not pregnant. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0960298
Sex: F
Age:
State: CA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: 1cm lymphadenopathy in the right groin and left supraclavicular area; This is a spontaneous report from a contactable physician (patient) reported for herself that a 32-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ELIZ84) via Intramuscular at left arm, on 06Jan2021 at single dose for COVID-19 immunisation. Medical history was none. Patient has no known allergies. Concomitant medications included oral contraceptive (OCP) and cetirizine hydrochloride (ZYRTEC). Patient previously received first dose of BNT162B2 (Pfizer, Lot number: EH9S99) via intramuscular at left arm on 16Dec2020 for COVID-19 immunisation at the age of 32 years old. Patient received her Pfizer vaccines at hospital on 16Dec2020 and 06Jan2021. After her second vaccination, she had noticeable 1cm lymphadenopathy in the right groin and left supraclavicular area on 07Jan2021. No treatment received for events. Patient did not receive other vaccine in four weeks. Patient did not test COVID post vaccination. Outcome of the event was recovering.

Other Meds: ; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0960299
Sex: F
Age:
State: TX

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fever; Headache; Achy Bones; Tiredness; Cough; Start Date/Time: 22Dec2020 04:00 AM; Dose Number:1/Start Date/Time: 08Jan2021 08:45 AM;Dose Number:2; This is a spontaneous report from a contactable other HCP reporting for herself. A 52-years-old female patient received the second dose of bnt162b2 (BNT162B2) vaccine , on 08Jan2021 08:45 in the left arm at single dose for Covid 19 immunization. Medical history included drug hypersensitivity Concomitant medication included lisdexamfetamine mesilate (VYVANSE), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), ergocalciferol (VIT D). The patient received the first dose of BNT 162B2 vaccine on 22Dec2020. On 08Jan2021, the patient received the second dose of BNT162B2 vaccine earlier than expected. On 09Jan2021 the patient experienced fever, headache, achy bones, tiredness, and cough The reported events were considered non serious and their outcome was recovering No follow-up attempts are possible: information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VYVANSE; VITAMIN C [ASCORBIC ACID]; VIT D

Current Illness:

ID: 0960300
Sex: M
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Sore Army near injection site; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number: EL1284) via an unspecified route of administration on arm left on 09Jan2021 07:30 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient previously took acetylsalicylic acid (aspirin) and experienced allergy. The patient was not diagnosed COVID prior vaccination. The patient was not COVID tested post vaccination. The patient experienced sore army near injection site on 10Jan2021 with outcome of recovering. No treatment received for the event.

Other Meds:

Current Illness:

ID: 0960301
Sex: F
Age:
State: CA

Vax Date: 12/19/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: some arm pain but lasted several hours and mild; This is a spontaneous report from a contactable Physician (patient). A 27-year-old female patient received first dose of bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE, lot number: EJ1685) at left arm, via an unspecified route of administration on 19Dec2020 12:00 at single dose for covid-19 immunisation. The patient did not have other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient had no known allergies, no other medical history. Concomitant medication included sertraline, ascorbic acid (VIT C), ergocalciferol (VIT D), zinc, cetirizine hydrochloride (ZYRTEC) and vitamin. After her first dose, the patient just had some arm pain but lasted several hours and mild on an unspecified date. The patient did not test COVID post vaccination. The outcome of event was recovered.

Other Meds: ; VIT C; VIT D; ; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0960302
Sex: F
Age:
State: TN

Vax Date: 12/20/2020
Onset Date: 12/22/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: diarrhea; weakness; fatigue; low grade fever/my fever reached 102; body aches; This is a spontaneous report from a contactable Nurse(patient). A 39-year-old female patient received first dose BNT162B2 (lot number EJ1685) , via an unspecified route of administration at Arm Left on 20Dec2020 12:15 at the 39 years old at single dose for COVID-19 immunization. The medical history included septic shock, from 2014 multi organ failure. There were no known allergies. The concomitant medications were topiramate(TROKENDI), lisdexamfetamine mesylate(VYVANSE), bupropion, sertraline, paracetamol(TYLENOL). On 22Dec2020 12:00 the patient started to have a low grade fever and body aches. On 23Dec2020 12:00 her fever reached 102 Fahrenheit, she had body aches, diarrhea, weakness and fatigue. This continued until 27Dec2020. The patient took Tylenol and Advil for fever. Tylenol and Advil helped some with fever but not always. There was no treatment received for body aches, diarrhea and weakness and fatigue. The events low grade fever, fever reached 102, body aches, diarrhea, weakness and fatigue resulted in Emergency Room Visit. There was no other vaccine in four weeks. The patient had not COVID prior vaccination. The patient had not COVID tested post vaccination. The outcome of the events was recovered on 27Dec2020.

Other Meds: TROKENDI; VYVANSE; ; ; TYLENOL

Current Illness:

ID: 0960303
Sex: F
Age:
State: VA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: tenderness at injection site; This is a spontaneous report from a contactable other hcp (patient). The 57-years-old female patient (not pregnant) received first dose of bnt162b2 (BNT162B2, lot number: EK4176), on left arm unknown on 09Jan2021 13:30 at SINGLE DOSE for covid-19 immunisation. Medical history was none. The patient did nor receive other vaccine in four weeks. The patient did not experience COVID prior the vaccination. The patient did not test covid post vaccination. No known allergies. Concomitant medication included alprazolam (XANAX), cetirizine hydrochloride (ZYRTEC DAIICHI), omeprazole (PRILOSEC), zolpidem tartrate (AMBIEN). The patient experienced tenderness at injection site on 10Jan2021 05:00, described as Woke up the next morning with tenderness at injection site. No swelling or redness. No treatment received for the event. The outcome of the event was recovering. No follow-up attempts possible. No further information expected.

Other Meds: XANAX; ZYRTEC DAIICHI; PRILOSEC [OMEPRAZOLE]; AMBIEN

Current Illness:

ID: 0960304
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: patient tested positive for COVID-19; patient tested positive for COVID-19; This is a spontaneous report from a contactable nurse (reporting for herself), via a Pfizer sponsored program. A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient tested positive for COVID-19. The patient underwent lab tests and procedures which included COVID-19: positive on an unspecified date. The outcome of the event was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 0960305
Sex: M
Age:
State: FL

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: vertigo; Extreme dizziness/ vertigo. To the point of falling.; feel lightheaded; extreme exhaustion; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, lot # Ek9231) at single dose at right arm on 07Jan2021 12:00 AM for Covid-19 immunisation, administered at hospital. Medical history included non-Hodgkin's lymphoma, allergy to penicillin. Concomitant medication included amlodipine (AMLODIPINE), lisinopril (LISINOPRIL), escitalopram (ESCITALOPRAM). The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. The patient experienced feel lightheaded on 08Jan2021 around 4 pm, extreme exhaustion on 08Jan2021 around 4 pm, vertigo to the point of falling on 08Jan2021 around 8 pm and feel lightheaded, and he was still feel lightheaded, not badly. No treatment received. Post vaccination, the patient has not been tested for COVID-19. The outcome of events was recovered with sequelae (recovered with lasting effects).

Other Meds: ; ;

Current Illness:

ID: 0960306
Sex: F
Age:
State:

Vax Date: 12/15/2020
Onset Date: 12/01/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: sore arms; This is a spontaneous report from a contactable Other HCP. This 35-year-old female Other HCP (patient) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Dec2020 for covid-19 immunization. Medial history and concomitant drug were not reported. Patient experienced sore arms, no other symptoms after received 1st dose. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960307
Sex: F
Age:
State:

Vax Date: 12/19/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: severe chills, fatigue, fever 100.7F, nausea; severe chills, fatigue, fever 100.7F, nausea; severe chills, fatigue, fever 100.7F, nausea; severe chills, fatigue, fever 100.7F, nausea; This is a spontaneous report from a non contactable physician reporting for herself. A 28-years-old female patient received bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on 19Dec2020 17:00 at single dose for Covid-19 immunisation . The patient medical history and concomitant medications were not reported. The patient experienced severe chills, fatigue, fever 100.7?F, nausea on an unknown date with outcome of recovering. The patient underwent lab tests and procedures which included body temperature: 100.7 Fahrenheit on an unspecified. Unspecified therapeutic measures were taken as a result of the reported events. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 0960308
Sex: F
Age:
State: MT

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Lymph node swelling unilaterally in the armpit on the side of the injection; Sore arm; some fatigue; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer, lot number: EL3246) via an unspecified route of administration at left arm on 06Jan2021, at 04:30 PM (dose number: 2) for COVID-19 immunization. Medical history included depression and anxiety. No known allergies. Historical vaccination included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer, Lot number: EH9899) via an unspecified route of administration at left arm on 17Dec2020 at 04:45 PM at a single dose (dose number: 1) for COVID-19 immunization. No other vaccine in four weeks. Other medications in two weeks included fluoxetine, ibuprofen, acetaminophen, cefixime (FLEXERIL). Facility type vaccine was at hospital. The patient was not pregnant. The patient experienced adverse events included lymph node swelling unilaterally in the armpit on the side of the injection, sore arm and some fatigue. The adverse event start date was reported as 08Jan2021 at 04:45 AM. No treatment received for events. The outcome of events was resolving. No COVID prior vaccination. No COVID tested post vaccination.

Other Meds: ; ; ACETAMINOPHEN; FLEXERIL

Current Illness:

ID: 0960309
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: patient received the second dose of the vaccine on 06Jan2021 and tested positive for the COVID virus 09Jan2021; patient received the second dose of the vaccine on 06Jan2021 and tested positive for the COVID virus 09Jan2021; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age ((Age: 50; Unit: Unknown; as reported) received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 06Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the second dose of the vaccine on 06Jan2021 and tested positive for the COVID virus 09Jan2021 (medically significant). The clinical course was reported as follows: The patient received the second dose of the vaccine on 06Jan2021 and tested positive for the COVID virus on 09Jan2021. The patient stated that she had signs and symptoms and had exposure to the COVID virus. The patient underwent lab tests and procedures which included COVID-19 virus test: positive on 09Jan2021. The clinical outcome of the events: drug ineffective and COVID-19 virus test positive, was unknown. The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0960310
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Sore at injection site.; This is a spontaneous report from a contactable other healthcare professional (patient). A 22-year-old female patient (no pregnancy) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at site of left arm on an unspecified date at single dose for COVID-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient experienced sore at injection site on an unspecified date. Facility type vaccine was in hospital. No other vaccine received in four weeks. No other medications received in two weeks. No treatment for adverse event. No covid prior vaccination. Covid (Nasal Swab, Rapid test) was tested with negative result post vaccination. No known allergies. The outcome of event was recovered on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0960311
Sex: F
Age:
State: OR

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Soreness at the injection site/arm; Soreness at the injection site/arm; I am currently breastfeeding at time of vaccination; I am currently breastfeeding at time of vaccination; This is a spontaneous report from a contactable consumer (patient). This consumer reported information for both mother and baby. This is the maternal report. This consumer (mother) reported for herself that: a 37-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: Ek9231), via an unspecified route of administration in Left arm on 08Jan2021 11:15 at single dose for COVID-19 immunization. Medical history included ongoing breast feeding. There were no Known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO), ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS). There were no other vaccines received in four weeks. The patient did not have covid-19 prior vaccination and did not have covid-19 tested post vaccination. The patient was currently breastfeeding at time of vaccination and would continue to do so. The patient experienced soreness at the injection site/arm starting a couple hours after administration on 08Jan2021 13:15 and lasting 1 day. The patient did not receive any treatment for events soreness at the injection site/arm. The outcome of events soreness at the injection site/arm was Recovered in Jan2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021022052 Same reporter/drug, different patient/event (baby/mother case)

Other Meds: LEXAPRO; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS

Current Illness: Breast feeding

ID: 0960312
Sex: M
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Myalgias; fatigue; sweats; headache; chills; Fever/T max 102.6; This is a spontaneous report from a contactable physician. This 32-year-old male physician (patient) reported for himself that he received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number= EL1283), via unspecified route at left arm on 08Jan2021 04:45 pm at single dose for COVID-19 immunization. Medical history and concomitant drugs were not reported. Historical vaccine included the first dose of BNT162B2 (lot number= EK5730) for COVID-19 immunization on 18Dec2020 04:45 pm at left arm. Facility type vaccine was hospital. No other vaccine in four weeks. No other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. On 09Jan2021 04:15 am, patient experienced fever/T max 102.6, myalgias, fatigue, sweats, headache and chills. No treatment was received for events. Outcome of events was recovering.

Other Meds:

Current Illness:

ID: 0960313
Sex: F
Age:
State: MI

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Mild feeling of throat constricting; dizziness; palpitations; Left arm sore; Circular rash next to injection site; This is a spontaneous report from a contactable other hcp (patient). A 52-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ELO140), via an unspecified route of administration in left arm on 06Jan2021 14:30 at single dose for COVID-19 immunization. Medical history included high blood pressure and brachial radial puritis. Concomitant medication included metoprolol succinate (TOPROL) and estrogens conjugated (PREMARIN). No COVID prior vaccination. No other vaccine in four weeks. The patient experienced mild feeling of throat constricting, dizziness, and palpitations, left arm sore, Circular rash next to injection site on 06Jan2021 14:45 (for about 20 minutes), left arm sore for about 4 days. No treatment received. No COVID tested post vaccination. The outcome of events was recovered in Jan2021.

Other Meds: TOPROL; PREMARIN

Current Illness:

ID: 0960314
Sex: U
Age:
State: OK

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: bad migraine; headache; nauseous; This is a spontaneous report from a contactable healthcare professional (patient). A 36-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular on 06Jan2021 07:00 to 06Jan2021 07:00 at 0.3 mL, single (SINGLE DOSE) for an unspecified indication. Medical history included polycystic ovaries (PCOS), endometriosis, irritable bowel syndrome (IBS), and known allergies: melons, all from unknown dates. Concomitant medication included amoxicillin, clavulanic acid (AUGMENTIN), ethinylestradiol, etonogestrel (NUVARING), acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL), cetirizine hydrochloride (ZYRTEC), diphenhydramine hydrochloride (BENADRYL). The patient experienced bad migraine, headache and was nauseous on 06Jan2021. Details were as follows: the patient had a bad migraine for three days after. On the Wednesday night (13Jan2021) after the injection, the migraine was so bad, that therapeutic measures taken; the patient took an unspecified medication and went to bed. The patient woke up three times in the night with a headache bad enough to make the patient nauseous. The second day was bad but manageable; on the third day it came and went.

Other Meds: AUGMENTIN [AMOXICILLIN;CLAVULANIC ACID]; NUVARING; EXCEDRIN MIGRAINE; NYQUIL; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; BENADRYL

Current Illness:

ID: 0960315
Sex: F
Age:
State: PA

Vax Date: 12/31/2020
Onset Date: 01/04/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: received the Vaccine on 31Dec and on 04Jan was tested positive; received the Vaccine on 31Dec and on 04Jan was tested positive; Low-grade fever; slight loss of smell and taste; slight loss of smell and taste; This is a spontaneous report from a contactable Consumer. A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 31Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient received the Vaccine on 31Dec2020 and on 04Jan2021 was tested positive prior to having surgery. Minimal symptoms. Low-grade fever, slight loss of smell and taste. Outcome of events was recovering. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0960316
Sex: F
Age:
State: CA

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: fever; Sore arm; body aches; headache; chills; Administration date=09Jan2021/Administration date=21Dec2020; This is a spontaneous report from a contactable nurse (patient). A 39-year-old female patient received second dose of BNT162B2 (Pfizer, lot number: EL1284), via an unspecified route of administration in left arm on 09Jan2021 18:00 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient previously received the first dose of BNT162B2 (lot number: E51685) in left arm on 21Dec2020 13:45 for COVID-19 immunization. On 10Jan2021 07:00, patient experienced sore arm, body aches, headache, chills, and fever. Treatment was not received for these events. Patient was not recovered from these events.

Other Meds:

Current Illness:

ID: 0960317
Sex: M
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: terrible headache/bad headache; body aches; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect from a contactable consumer (patient) and another consumer (Wife). A 79-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 09Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 at single dose for COVID-19 immunization. Patient was experiencing body aches and terrible headache after 2nd dose of vaccine. Patient wanted to know if he could use analgesics after vaccination with the Pfizer-BioNTech COVID-19 vaccine. The patient's wife further reported that her husband had his second dose of Covax on 09Jan2021. Today (10Jan2021) he was experiencing body aches and a bad headache and wondering if he can take pain reliever. The outcome of the events was not recovered at the time of the reporting. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960318
Sex: M
Age:
State: FL

Vax Date: 12/31/2020
Onset Date: 01/04/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: have a persistent severe headache; feverish; I feel very light headed; unsteady with difficulty maintaining balance when I walk; This is a spontaneous report from a contactable healthcare professional (patient). A 61-year-old male patient received the first dose of BNT162B2 (Pfizer, lot number: EH9899), via an unspecified route of administration in left arm on 31Dec2020 12:00 at single dose for COVID-19 immunization. Medical history included known allergies: penicillin, and deep vein thrombosis (DVT). Concomitant medications in two weeks included dabigatran etexilate mesilate (PRADAXA) at 150 mg twice a day, and hydrochlorothiazide/losartan potassium (LOSARTAN + HIDROCLOROTIAZIDA) at 100-25 mg. On 04Jan2021, patient felt very light headed, unsteady with difficulty maintaining balance when I walk, had a persistent severe headache and feverish. However, he did not have a fever. Temperature was 97.5. Blood pressure (BP) was normal. Pulse was normal. No soreness at the injection site from day one. Treatment was not received. Patient was not recovered from all these events.

Other Meds: PRADAXA; LOSARTAN + HIDROCLOROTIAZIDA

Current Illness:

ID: 0960319
Sex: F
Age:
State: MI

Vax Date: 01/04/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Experience skin nerve pain all over my body; Experience skin nerve pain all over my body; Extreme cold sensation after bowel movements; This is spontaneous report from a contactable other HCP (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number not provided), via an unspecified route of administration on 04Jan2021 10:15 at single dose for covid-19 immunization. Patient is not pregnant. Medical history included severe post concussion syndrome (5 major concussions), anxiety, depression, raynaud's syndrome, pineal gland cyst (last MRI Oct2020 reveal cyst was 12mm). The known allergies included Cipro, sensitive to many food, high allergy to mold, grasses, trees. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), fluoxetine hydrochloride (PROZAC), rizatriptan benzoate (MAXALT), montelukast sodium (SINGULAIR), levocetirizine dihydrochloride (XYZAL) , lactulose (LACTUL), ongoing medications included mometasone furoate (FLONASE), budesonide (BUDESONIDE), olopatadine (OLOPATADINE), ipratropium (IPRATROPIUM) , fremanezumab (AJOVY), allergy shots. 48 hours after injection on 06Jan2021 13:00, patient began to experience skin nerve pain all over body accompanied with extreme cold sensation after bowel movements, has been 6 days and getting worse. She will be going to urgent care tomorrow. She was between primary care physicians until 13Jan2021. Patient didn't receive treatment for the adverse events. The outcome of events was not recovered. Information about lot/batch number has been requested.

Other Meds: ADDERALL; PROZAC; MAXALT; SINGULAIR; XYZAL; LACTUL; FLONASE; ; ; ; AJOVY

Current Illness:

ID: 0960320
Sex: F
Age:
State: OK

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: extreme discomfort; sharp pain in my upper back primary on the right side of my body; sharp pain in my upper back primary on the right side of my body; Most of the sharp pain was when coughing; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer PAA156051; lot number: EK9231) via an unspecified route of administration at right arm on 08Jan2021 at 09:30 AM at a single dose (dose number: 1) for COVID-19 immunization. Medical history was reported as none. No known allergies. No other vaccine in four weeks. Other medications in two weeks included birth control. Facility type vaccine was other. The patient was not pregnant. The patient felt extreme discomfort and sharp pain in her upper back primary on the right side of her body starting Friday 08Jan2021 evening until late Saturday night 09Jan2021. Most of the sharp pain was when coughing or inhaling and while sitting and laying down only. I did not have extreme plain when standing up. The start date of events was reported as 08Jan2021 at 05:30 PM. Treatment received included OTC Bayer for the pain. The outcome of events was resolved on 09Jan2021. No covid prior vaccination and no covid tested post vaccination.

Other Meds:

Current Illness:

ID: 0960321
Sex: F
Age:
State: ID

Vax Date: 12/28/2020
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Several toes on my right foot and one toe on my left became purple in color and looked like "COVID toes."; Stiff Neck noted in correlation with discoloration; This is a spontaneous report from a contactable Nurse reported for herself. A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140), intramuscular at right arm on 28Dec2020 15:30 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included Factor V, Behcet's disease, Hypertension, and allergy to PCN. Prior to vaccination, the patient was not diagnosed with COVID-19 The patient's concomitant medication was not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's past drug history included steriod Injection to left shoulder 23Dec2020. On 09Jan2021 11:30, Approximately 12 days after receiving vaccine, several toes on my right foot and one toe on my left became purple in color and looked like "COVID toes." I was seen in the ED, unsure of what is causing this, will be seen by MD next week. Lighter purple on second day, seems to be resolving. Stiff Neck noted in correlation with discoloration. Adverse event resulted in: Emergency room/department or urgent care. No treatment received for the events. The patient underwent lab tests and procedures which included Nasal Swab 2019 Novel Coronavirus SARSCOV-2 by PCR was negative on 09Jan2021. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0960322
Sex: F
Age:
State: NM

Vax Date: 12/23/2020
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: headache; swollen lymph nodes; back pain; This is a spontaneous report from a contactable pharmacist (patient). A 26-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced delayed reactions of headache, and back pain and swollen lymph nodes started on 07Jan2021 and continue to this day (4 days as well) on 07Jan2021 with outcome of not recovered. Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960323
Sex: U
Age:
State:

Vax Date: 12/22/2020
Onset Date:
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Patient tested positive for COVID after first dose; Patient tested positive for COVID after first dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a patient of an unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number/expiration date unknown) via an unspecified route of administration on 22-Dec-2020 (19 days before 10-Jan-2021) at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient tested positive for COVID after first dose. Reporter would like to know how he should proceed for second dose. The outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960324
Sex: M
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: injection site pain; nausea; feeling unwell; reduced appetite; loose stools with an off odor; loose stools with an off odor; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not provided), via an unspecified route of administration on 07Jan2021 (Thursday) at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. He stated that at first he had injection site pain in Jan2021 which has now gotten better but was currently experiencing nausea, feeling unwell, reduced appetite, loose stools with an off odor in Jan2021. He was asking how long these symptoms usually last. The patient wondered if he can get the second dose since he had these symptoms with the first dose. The outcome of event injection site pain was recovering, the outcome of the other events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960325
Sex: F
Age:
State: NY

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: she had pressure headaches; she had pressure headaches and it extends to the back of her head and neck; she had pressure headaches and it extends to the back of her head and neck; This is a spontaneous report from a contactable Other HCP(patient). A 37-year-old female patient received BNT162B2 (lot number E13246) , Intramuscular at Arm Left on 07Jan2021 09:30 at the 37 years old at single dose for COVID-19 immunization. The medical history included Shellfish allergy. The concomitant medications were none. Since taking the vaccine on Thursday morning, starting Friday morning on 08Jan2021 she had pressure headaches and it extends to the back of my head and neck. There was no treatment received for all the adverse events. There was no other vaccine in four weeks. There was no covid prior vaccination. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 0960326
Sex: F
Age:
State: GA

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Tiredness; headache; chills; fever; muscle pain; This is a spontaneous report from a contactable Nurse(patient). The 54-year-old female patient (not pregnant) received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number ES1655) , via an unspecified route of administration at right arm on 09Jan2021 10:00AM at single dose for covid-19 immunisation. Medical history included arthritis, asthma, sjogren, eczema. The patient's concomitant medications were not reported. The patient previously took cefotaxime sodium (OMNICEF) and "Bactria" and both experienced drug allergy. The patient experienced tiredness, headache, chills, fever, muscle pain, all on 10Jan2021 at 12:00 AM with outcome of not recovered. There was no treatment received, no covid prior vaccination, no covid tested post vaccination.

Other Meds:

Current Illness:

ID: 0960327
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: body aches; insomnia; chills; bouts of nausea; This is a spontaneous report from a non-contactable Other healthcare professional (patient). A 34-year-old male patient received his second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number= EL3246), intramuscular on left arm on unspecified date in Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received his first dose of BNT162B2 intramuscularly on left arm on unknown date for COVID-19 immunization. 10hrs after his second vaccination on 09Jan2021, the patient developed body aches, insomnia and chills, he also had been bouts of nausea. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any treatment for events. The outcome of events was recovered in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0960328
Sex: F
Age:
State: AL

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: extreme joint and muscle aches (ankles,elbows,hips,lower back,calves were the worst)/aches and joint pain continued but less intense, arches of feet to fingers, hips and lower back were most prominent; extreme joint and muscle aches (ankles,elbows,hips,lower back,calves were the worst)/aches and joint pain continued but less intense, arches of feet to fingers, hips and lower back were most prominent; extreme joint and muscle aches (ankles,elbows,hips,lower back,calves were the worst)/aches and joint pain continued but less intense, arches of feet to fingers, hips and lower back were most prominent; fever/low grade fever; nausea; gas which lead to vomiting; gas which lead to vomiting; extreme joint and muscle aches even after 1gm of Tylenol (ankles, elbows, hips, lower back, calves were the worst)/ lower back pain; chest similar to what one would experience during hyperventilation; tingling feeling in hands/fingers, lips; tingling feeling in hands/fingers, lips; headache; Slept most of the day evening; This is a spontaneous report from a contactable nurse (reported for herself). A 37-year-old female patient (not pregnant) received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283), via an unspecified route of administration on 08Jan2021 10:15 at single dose at right arm for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication received in two weeks included lisdexamfetamine mesilate (VYVANSE) in two weeks (did not take on vaccine days). The patient previously received the first dose of bnt162b2 (lot number: EJ1685) on 18Dec2020 10:00 at single dose at right arm for COVID-19 immunization. No other vaccine in four weeks. On 09Jan2021 12:00, 12hrs after injection extreme joint and muscle aches even after 1gm of Tylenol (ankles, elbows, hips, lower back, calves were the worst), fever, nausea/gas which lead to vomiting (even after 25mg phenergan) and headache this last 6hrs. The aches and joint pain continued but less intense, arches of feet to fingers, hips and lower back were most prominent. Tylenol did not relieve symptoms, but was able to sleep. Slept most of the day evening in Jan2021. 48/60hrs after injection the lower back pain remains intense as well as low grade fever (Jan2021). Also have a tingling feeling in hands/fingers, lips, chest similar to what one would experience during hyperventilation on 09Jan2021 12:00. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient didn't have Covid prior vaccination and didn't have Covid tested post vaccination. The outcome of Arthralgia and Pain in extremity was recovering, of Pyrexia and Low back pain was not recovered, of the other events was unknown.

Other Meds: VYVANSE

Current Illness:

ID: 0960329
Sex: F
Age:
State: MO

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: body aches; fevers; nausea; This is Spontaneous report from a contactable consumer. A 30-year-old female patient received second dose BNT162B2, via an unspecified route of administration on 07Jan2021 at the 30 years old at single dose for COVID-19 immunization. The medical history and concomitant medications were not reported. The Historical Vaccine included BNT162B2 for COVID-19 immunization (dose number 1). The patient was a nurse and she and several of her colleagues received the second dose of COVID-19 vaccine on Thursday 07Jan2021. On Friday 08Jan2021, she and many of her colleagues woke up with body aches, fevers, and nausea. She said the side effects went away within 12- 24 hours. There was no treatment received for all the adverse events. The outcome of the event was recovered in Jan2021. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960330
Sex: F
Age:
State: MO

Vax Date: 01/08/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Rash on upper body; This is a spontaneous report from a contactable healthcare professional (patient). A 27-year-old female patient received the first dose of BNT162B2, intramuscularly in right arm on 08Jan2021 15:30 at single dose for COVID-19 immunization. Medical history was none. Concomitant medications were unspecified. On 10Jan2021 15:00, patient experienced rash on upper body. Treatment was not received for this event. Outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960331
Sex: F
Age:
State: LA

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Fever; difficulty breathing; fast heartbeat; This is a spontaneous report from a contactable Other HCP (patient). This 31-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 12:30 at single dose on the left arm for COVID-19 immunization. Medical history included allergies: PCN. Concomitant medications included galcanezumab (EMGALITY) received in two weeks. No other vaccine received in four weeks. Patient was not pregnant. Facility type vaccine was hospital. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 09Jan2021 18:00, the patient experienced fever, difficulty breathing, fast heartbeat. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Outcome of the events was not recovered. Information about Lot/batch number has been requested.

Other Meds: EMGALITY [GALCANEZUMAB]

Current Illness:

ID: 0960332
Sex: F
Age:
State: CA

Vax Date: 12/19/2020
Onset Date: 12/19/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: LUE pain; bone pain; mialgia/muscle aches; all over joint pain; fatigue; chills; sore Left deltoid; body aches/all over body aches; Headache; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EK5730), intramuscular on 19Dec2020 07:00 am at single dose at left arm for covid-19 immunization. Medical history included hypertension, covid-19 (prior vaccination). No known allergies. Concomitant medications in two weeks included amlodipine besilate (NORVASC), ascorbic acid (VIT C), ergocalciferol (VIT D), magnesium chloride (MAG), zinc and daily multivitamins. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, patient had not been tested for COVID-19. The patient experienced sore left deltoid, body aches, headache all on 19Dec2020 16:00, all over body aches, headache, fatigue and chills all on 20Dec2020, mialgia/muscle aches, fatigue, headache and all over joint pain all on 21Dec2020, headache, LUE pain, muscle and bone pain, fatigue all on 22Dec2020, patient finally felt better with decreased symptoms on 23Dec2020. Outcome of all events was recovered on unspecified date. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care. Patient received paracetamol (TYLENOL), motrin for events.

Other Meds: NORVASC; VIT C; VIT D; MAG [MAGNESIUM CHLORIDE];

Current Illness:

ID: 0960333
Sex: F
Age:
State: CO

Vax Date: 12/20/2020
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Nausea; Vomiting; Body aches; Chills; Low grade fever 99.8; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse reported for herself that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunization. The patient medical and concomitant medications were not reported. The patient experienced nausea, vomiting, body aches, chills, and low grade fever 99.8 on 08Jan2021. She stated that she has been afebrile for 24 hours. She was scheduled to receive the second dose on 10Jan2021. She did have a PCR send off test for COVID-19 but had not yet received the results. She stated that she did not think she has COVID-19 but she was not sure. She was wondering if she should still get the second dose of the vaccine on 10Jan2021. The outcome of fever was recovered in Jan2021, of the other events was unknown. She stated that her institution was telling her if she delay getting her second dose of the COVID-19 vaccine then she would need to restart the vaccination series. She would like to know if this information was accurate. Information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0960334
Sex: F
Age:
State: PA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Soar throat; Chills; Tired; Runny nose/ Felt like nose flu; Arm sore; This is a spontaneous report from a contactable Nurse. A female patient of an unspecified age (Age: 27; Unit: Unknown) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced arm sore on 04Jan2021, soar throat on 07Jan2021, chills on 07Jan2021, tired on 07Jan2021, runny nose/ felt like nose flu on 07Jan2021 Outcome of events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0960335
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Fever/body ache on day 4; Fever/body ache on day 4; Headache on day 2 and 3; This is a spontaneous report from a non-contactable consumer (patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686) via an unspecified route of administration at left arm on 06Jan2021 14:45 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced headache on day 2 (reported as 08Jan2021) and 3, fever/body ache on day 4 (10Jan2021). Patient received Ibuprofen as treatment for the events. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0960336
Sex: F
Age:
State: CO

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: feeling malaise; general soreness/Body and joints with extreme pain everywhere it touched the mattress; no real taste; chest pressure/tightness/ general pressure in the chest; SOB/ SOB with movement; Body and joints with extreme pain everywhere it touched the mattress; a screw in left foot, it felt like it was on fire at some point during the night; My left leg ached up into my hip; fever 99.9; HA; eye pain; intermittent nausea; This is a spontaneous report from a contactable nurse (patient). This 51-year-old female patient (non-pregnant) received the second single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142) on 07Jan2021 at 11:15, in right arm, for COVID-19 immunisation. Medical history included asthma, allergies to latex, banana, kiwi and acetylsalicylic acid (ASPIRIN). The patient received the first dose of BNT162B2 vaccine on 17Dec2020 at 19:45, lot number EJ1685, in right arm. The patient had no COVID prior vaccination. No other vaccine was given in 4 weeks. COVID was not tested post vaccination. Concomitant medications included thyroid (ARMOUR THYROID) and escitalopram. On 07Jan2021 at 12:30 the patient began experiencing SOB; assumed it was asthma, 2 puffs of albuterol were taken. At 13:30 she had still SOB with chest pressure/tightness, no change, no cough, no feeling appropriate, 2 puffs albuterol. At 14:15 reported to the vaccination clinic and told them of symptoms, SOB with movement and general pressure in the chest. 2 paracetamol (TYLENOL) were taken. She had to check into the ER for observation. Oxygen saturation was checked for 2 hours. No change in symptoms, no worsening. She then left work in the ER and went home. At approximately 18:00 she ate dinner, no real taste, but needed to eat. At 18:30 she showered, at 20:00 she went to bed just feeling malaise, continued pressure in the chest and general soreness. 2 Tylenol. Body and joints with extreme pain everywhere it touched the mattress. She had a screw in her left foot, it felt like it was on fire at some point during the night. Her left leg ached up into her hip, she had fever 99.9, continued to 10Jan2021 with malaise, HA, eye pain, intermittent nausea. The events had not yet resolved at the time of report.

Other Meds: ARMOUR THYROID;

Current Illness:

ID: 0960337
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: moderate diarrhea; incredible soreness to injection site (left deltoid); general malaise tiredness within 2 hours of administration; general malaise tiredness within 2 hours of administration; This is a spontaneous report from a non-contactable nurse reporting for herself. A 38-year-old female patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0142, expiry date not reported) on 06Jan2021 intramuscularly in the left arm for COVID-19 immunization. There was no relevant medical history and no concomitant medications. The patient had not had COVID prior to the vaccination and she was not tested post the vaccination. On 06Jan2021, the patient experienced general malaise tiredness within 2 hours of administration. On 07Jan2021, she experienced severe soreness (stated as "incredible soreness") to injection site (left deltoid). On 08Jan2021, she experienced moderate diarrhea (per CDC systemic reaction classification). The events were non-serious. No treatment received for the events. The events were resolved on an unspecified date in Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0960338
Sex: F
Age:
State: NY

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Throbbing pain; tingling fingers in left arm; pain going up the neck of left side; fever; chills; joint pain (both shoulders, low back, hips, and knee); loss of appetite; fatigue; weakness; headache; muscle pain; This is a spontaneous report from a contactable Other HCP (patient). This 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via Intramuscular on 08Jan2021 on Arm left at single dose (Lot # 3249) for covid-19 immunisation. Medical history included Osteoporosis, vitamin D deficient. No known allergies. No other vaccine in four weeks. Concomitant medications included other medications in two weeks. She experienced throbbing pain and tingling fingers in left arm, pain going up the neck of left side. Also experience typical side effects: fever, chills, joint pain (both shoulders, low back, hips, and knee), loss of appetite, fatigue, weakness, headache, and muscle pain on 09Jan2021. No Covid prior vaccination. No covid tested post vaccination. No treatments received. Outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0960339
Sex: F
Age:
State: MO

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Dizziness; brain fog; achy; chills; sore arm; This is a spontaneous report from a contactable other HCP(patient). A 48-year-old female patient received first dose BNT162B2, via an unspecified route of administration at Arm Right on 30Dec2020 10:00 at the 48 years old at single dose for COVID-19 immunization. The medical history included Rheumatoid arthritis and Depression. The concomitant medications were hydroxychloroquine phosphate ( PLAQUENIL ), leflunomide(ARAVA), desvenlafaxine succinate(PRISTIQ). The patient previously took Methotrexate and experienced allergies. On 31Dec2020 11:00, the patient experienced Dizziness, brain fog, achy, chills, sore arm. Mild for maybe 6 hours and a couple hours were moderate. Woke the next day on 01Jan2021 feeling fabulous. There was no treatment received for all the adverse events. There was covid tested post vaccination. There was no other vaccine in four weeks. The patient underwent lab tests and procedures, which included Nasal Swab on 30Oct2020 Negative. The outcome of the events was recovered on 01Jan2021. Information about lot/batch number has been requested.

Other Meds: PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]; ARAVA; PRISTIQ

Current Illness:

ID: 0960340
Sex: F
Age:
State: FL

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Swelling in face at temples where I had filler a year ago; right eye area swelled up more until eye was almost closed; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El3246), via an unspecified route of administration on 10Jan2021 12:30 at single dose in left arm for covid-19 immunization. Illness at vaccine included urinary tract infection from Jan2021 and ongoing. Medical history included face at temples where she had filler a year before (in 2019). Concomitant medication included nitrofurantoin for urinary tract infection from 04Jan2021 to 11Jan2021. The patient had historically gotten shingles vaccine, flu vaccine and pneumonia vaccine and never had any problems. The patient experienced swelling in face at temples where she had filler a year before (in 2019) and right eye area swelled up more until eye was almost closed on 10Jan2020 17:00. This consumer had the bnt162b2 on 10Jan2021 at about 12:30pm. On 10Jan2021 around 4:00 pm (reported as "10Jan2020 05:00 pm") she noticed the areas around her temples and under eyes where she had filler placed last year swelled up quite a bit. She read up on this and saw to take antihistamines or oral steroids for this, so she took antihistamines and the event improved, was much better through during the day yesterday (11Jan2021). Last night (11Jan2021) her right eye area swelled up more until eye was almost closed; in response to that event she has been icing the area and the event has improved, swelling come down quite a bit but still ongoing. She called her primary care physician about this event and is waiting for a callback from them about getting a steroid pack. She already reported this information on an unknown Pfizer website online, and also on the VAERS reporting online site today (12Jan2021); but does not have any reference numbers from those reports to provide at this time. She called to ask for information on how to proceed regarding this event; if this has been reported with bnt162b2; if there would be problems with her getting the second dose of bnt162b2 as scheduled on 31Jan2021 because she heard the second dose would be worse. She also noted during this report that she was still taking nitrofurantoin for urinary tract infection when she received that first dose of bnt162b2; she asked if that could have any correlation with event or be a problem taken together. She reported by the time she got that first dose the urinary tract infection itself was gone. Caller verified that she received no other vaccines on the date of first dose of bnt162b2 and onset of adverse event. She verified that she had not received any other vaccines in the 4 weeks prior to the first dose of bnt162b2 and onset of adverse event. She verified that she has no history of any adverse events with any other vaccines. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0960341
Sex: F
Age:
State: OK

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: fatigue; malaise; severe headache; chills; myalgia; arthralgia; temperature fluctuations; lightheaded ness; diaphoresis; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 34-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, on 17Dec2020 at 17:00 (Lot # EK5730) via intramuscular route in right arm and the second dose on 07Jan2021 at 17:30 (Lot # EK9231), at 34 years of age, via intramuscular route in left arm, both at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination and had no relevant medical history and no known allergies. She was vaccinated in hospital. Concomitant medication included sertraline hydrochloride (ZOLOFT), cetirizine hydrochloride (ZYRTEC) and mometasone furoate (FLONASE). On 08Jan2021 at 16:00 the patient experienced fatigue, malaise, severe headache, chills, myalgia, arthralgia, temperature fluctuations, lightheadedness and diaphoresis. No treatment was received for the reported events. At the time of the report the reported events had not resolved yet. The patient commented that these events may still be considered normal, but she still had been experiencing them 3 days post vaccine, they have persisted long enough and she thought she should report them.

Other Meds: ZOLOFT; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLONASE [MOMETASONE FUROATE]

Current Illness:

ID: 0960342
Sex: F
Age:
State: NY

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Got acute pain in my stomach/stomach pain; Diarrhea; Passed undigested food; Fatigue; A little confusion; Muscle pain at the site of injection; The site was also hot and swollen for at least 12 hours; The site was also hot and swollen for at least 12 hours; This is a spontaneous report from a contactable Other HCP. This 37-year-old female Other HCP (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK3730, Expedite date:Mar2021 ) at single dose for COVID-19 immunization on 31Dec2020, 10:30 AM. Relevant history was unknown. Relevant concomitant drugs included citalopram 40mg daily, alprazolam 0.5 mg as needed. About 3-4 hours after injection, the patient got acute pain in her stomach. She had diarrhea and stomach pain for 5 days. She passed undigested food for about 3 days. Day of injection she had fatigue, a little confusion, and muscle pain at the site of injection. The site was also hot and swollen for at least 12 hours. No treatment was received. The outcome of events was resolved. The patient had not COVID prior vaccination. The patient had not have COVID tested post vaccination.

Other Meds: ;

Current Illness:

ID: 0960343
Sex: F
Age:
State: MN

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/21/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: fever; pulsating migraine; joint and muscle aches and pains; joint and muscle aches and pains; dizziness; fatigue; First dose on 21Dec2020, second dose on 06Jan2021; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself. A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular at Left arm on 06Jan2021 15:15 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included swine flu. Concomitant medications included buspirone, venlafaxine, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL XR), ethinylestradiol, levonorgestrel (AVIANE) for birth control, plantago ovata fibre (FIBER SUPPLEMENT), probiotics and women's multi-vitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's historic vaccine included first dose of BNT162B2 (lot number: EL0140), Intramuscular at left arm on 21Dec2020 15:15 for covid-19 immunization. On 07Jan2021 11:00, the patient experienced fever, pulsating migraine, joint and muscle aches and pains, dizziness, fatigue - absolutely could not have went to work if she was scheduled that day - just moving from her left side onto her right side took immense effort and tears - haven't experienced anything like it since she had swine flu. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events fever, pulsating migraine, 'joint and muscle aches and pains', dizziness, fatigue was recovered on an unknown date in Jan2021.

Other Meds: ; ; ADDERALL XR; AVIANE; FIBER SUPPLEMENT;

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm